跳转至内容
Merck
CN

G006340

UHPLC Analysis of Methotrexate and Related Compounds on Ascentis® Express C18

application for UHPLC

登录查看公司和协议定价

选择尺寸


技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

技术

UHPLC: suitable

试验参数

column: Ascentis Express C18, 10 cm x 2.1 mm I.D., 2.0 μm particles (50813-U)
mobile phase: [A] 10 mM ammonium formate, pH 3.0 with formic acid; [B] acetonitrile; (90:10, A:B)
flow rate: 0.7 mL/min
pressure: 1153 psi (795 bar)
column temp.: 35 °C
detector: UV, 254 nm
injection: 1 μL
sample: 50 μg/mL in 85:15, water:methanol

适用性

application for UHPLC

应用

pharmaceutical (small molecule)

分析说明

Methotrexate (MTX) has been selected as a tracer of surface contamination exposure of hospital staff to antineoplastic drugs (ANDs). Its analysis is an emerging facet of occupational medicine in hospital premises. Methotrexate and the related compounds aminopterin and folic acid are shown here separated by UHPLC on an Ascentis Express C18 column in less than two minutes. The rapid, high resolution separation means the method can be employed in hospitals or clinical settings to routinely monitor the contamination levels of surfaces.

法律信息

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

分析物

说明

    Aminopterin, powder
    Folic acid, analytical standard
    Methotrexate hydrate, ≥98% (HPLC), powder

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持